NDC 0069-0106 – Elelyso
Taliglucerase Alfa 200 U/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC0069-0106
Product details
- Brand name
- Elelyso
- Generic name
- Taliglucerase alfa
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA022458
- Marketed since
- May 1, 2012
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Active ingredients
- Taliglucerase Alfa 200 U/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-0106-01 | 1 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS | May 1, 2012 |
Recalls mentioning this NDC
- D-0995-2020 Mar 11, 2020 · Class II
Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button. - D-0005-2019 Oct 10, 2018 · Class II
Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.